Search

Displaying results 8891 - 8900 of 10000 in total
  1. Drug

    Gingerol

    go.drugbank.com/drugs/DB19255
    Investigational

    Gingerol is under investigation in clinical trial NCT05882864 (Efficacy of Ginger Muco-bioadhesive Gel in Management of Oral Lichen Planus With Immunohistochemical Analysis).

  2. Drug

    Bafisontamab

    go.drugbank.com/drugs/DB16091
    Investigational

    EMB-01 is under investigation in clinical trial NCT03797391 (A Dose Escalation Study of EMB-01 in Participants With Advanced/metastatic Solid Tumors).

  3. Drug

    Tinostamustine

    go.drugbank.com/drugs/DB15147
    Investigational

    Tinostamustine is under investigation in clinical trial NCT03452930 (Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma).

  4. Drug

    Tirabrutinib

    go.drugbank.com/drugs/DB15227
    Investigational

    Tirabrutinib is under investigation in clinical trial NCT02626026 (Safety and Pharmacokinetics of GS-4059 in Healthy Volunteers and Subjects With Rheumatoid Arthritis (RA)).

  5. Drug

    Panobacumab

    go.drugbank.com/drugs/DB15342
    Investigational

    Panobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa).

  6. Drug

    Cenersen

    go.drugbank.com/drugs/DB15455
    Investigational

    Cenersen is under investigation in clinical trial NCT02243124 (A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)).

  7. Drug

    ZEN-3694

    go.drugbank.com/drugs/DB22031
    Investigational

    ZEN-3694 is under investigation in clinical trial NCT04840589 (Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors).

  8. Drug

    IN01

    go.drugbank.com/drugs/DB16434
    Experimental

    Of note, the IN01 vaccine is being tested in a Phase I clinical trial in patients with fibrosing interstitial lung disease resulting from SARS-CoV-2 infection (NCT04537130). … The study will explore the effect of this vaccine on pulmonary function, oxygen saturation, quality of life, and fibrosing status in addition to biomarkers and molecular markers of the vaccine.

  9. Drug

    Omberacetam

    go.drugbank.com/drugs/DB19956
    Experimental

    Omberacetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Omberacetam is a piracetam type amide type nootrope agent.

  10. Drug

    Vibozilimod

    go.drugbank.com/drugs/DB21505
    Experimental

    Vibozilimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Vibozilimod is a immunomodulator, both stimulant/suppressive and stimulant.